Electrochemiluminescence for Electric-Driven Antibacterial Therapeutics

Area of Science:

• Biomedical Engineering
• Photochemistry
• Materials Science

Background:

• Clinical photodynamic therapy (PDT) is limited by light penetration depth for treating deeper tissue lesions.
• Existing PDT systems rely on external physical light sources, posing practical challenges.

Purpose of the Study:

• To develop a novel electric-driven luminous system for antibacterial applications using electrochemiluminescence (ECL).
• To create a new strategy, termed ECL-therapeutics, for generating reactive oxygen species (ROS) without external light.
• To design a practical, persistent antibacterial hydrogel device.

Main Methods:

• Constructed an electric-driven ECL system utilizing luminol and a cationic oligo(p-phenylenevinylene) (OPV) photosensitizer.
• Investigated the energy transfer mechanism from ECL to the photosensitizer for ROS generation.
• Integrated the ECL system into a flexible hydrogel matrix to create a persistent antibacterial device.

Main Results:

• Successfully generated ROS via ECL, enabling photosensitizer excitation without external light.
• Demonstrated persistent luminescence lasting over 10 minutes after brief electrical stimulation due to slow hydrogel reactions.
• Developed stretchable hydrogel devices with integrated persistent ECL and antibacterial functions.

Conclusions:

• ECL-therapeutics offers a novel, light-source-free approach for antibacterial treatment, expanding ECL applications beyond sensors.
• The developed hydrogel devices provide a simple, convenient, and controllable method for persistent antibacterial applications.
• This strategy opens a new model for photodynamic therapy, overcoming depth penetration limitations.